Latest Regenerative iPSC News

Subscribe

Longeveron Licenses Stem Cells from the University of Miami for Heart Disease

The technology aims to generate safer heart muscle cells for cardiovascular disease therapies and research.

Stem Cell Trial: iPSCs for Repairing Airway Damage in COPD

The study will test whether induced pluripotent stem cells can help repair airway damage in people with COPD.

Stem Cell Trial: BlueRock Launches Study of iPSC-Derived Photoreceptor Cell Therapy for Inherited Retinal Diseases

The trial will test whether lab-grown photoreceptor cells can be safely transplanted to help people with inherited vision loss.

New Trial: iPSC-Derived Exosome Therapy for Moyamoya Disease

Researchers are testing whether exosomes from stem cells can enhance blood vessel repair for Moyamoya patients after surgery.

Sana Biotechnology Reports Positive Results in Type 1 Diabetes Study Using Transplantation Without Immunosuppression

Sana Biotechnology reported six-month clinical data demonstrating successful survival and function of transplanted islet cells without immunosuppressive medication.

BlueRock Therapeutics Begins Phase 1/2a Trial of Stem Cell Therapy OpCT-001 for Retinal Diseases

The Bayer owned company just starting dosing patients with OpCT-001, an iPSC-derived cell therapy aiming to restore vision in inherited retinal diseases.

UniXell Biotechnology doses first Parkinson’s patient with iPSCs, reports improvements

The Chinese biotech company reports that the patient showed notable improvements in sleep quality and motor function, with no serious adverse events.

Trailhead Biosystems launches iPSCs for blood-brain barrier and neurological research

Researchers may now have a new tool to unlock insights into blood-brain barrier regulation and neurological disease mechanisms.

TreeFrog Therapeutics nabs €30M in funding to accelerate its iPSC technology, planning Parkinson’s trial in 2027

TreeFrog has developed a proprietary iPSC manufacturing process called C-Stem, moving one step closer to human trials.

Stem cell-based alternative to in vitro maturation reports double the pregnancy rate

The company uses iPSCs to create a replica environment for maturing eggs ex vivo, and the data looks promising as they roll into Phase 3.
Load More
x
Subscribe
Subscribe

Stay updated on Regenerative Medicine

Subscribe